Icatibant Injection, Solution
Product Images NDC 55150-351

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 55150-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2 Time To 50% Reduction From Baseline In 3-item Vas Score (Icatibant Fig1)

A Kaplan-Meier curve graph comparing the proportion of patients not achieving a 50% reduction in symptoms over time after dosing. The solid line represents patients treated with Icatibant (N=43), and the dashed line represents patients receiving placebo (N=45). The x-axis shows time from dose in hours, and the y-axis shows the proportion of patients not achieving symptom reduction.*

FDA Label Image

Figure I (Icatibant Fig10)

An instructional line drawing illustration of a hand holding a syringe prepared for injection. The syringe is shown with an extended plunger and needle tip pointing outward, suitable for subcutaneous administration.*

FDA Label Image

Figure J (Icatibant Fig11)

An instructional line drawing showing a hand administering a subcutaneous injection into the abdomen, illustrating the proper injection site technique for a subcutaneous injection.*

FDA Label Image

Figure K (Icatibant Fig12)

An instructional diagram showing two hand positions for subcutaneous injection. The left illustration indicates inserting the syringe needle at a 45-degree angle, while the right illustration shows insertion at a 90-degree angle. An angular reference diagram is also included to clarify the angles.*

FDA Label Image

Figure L (Icatibant Fig13)

An illustration depicting the administration of a subcutaneous injection into the abdominal area, showing a syringe held by one hand and pinch of the skin by the other. This instructional image is relevant to subcutaneous injection techniques used for drugs like Icatibant injection solution.*

FDA Label Image

Figure M (Icatibant Fig14)

An instructional illustration showing the technique for a subcutaneous injection. It depicts a hand holding a syringe and administering the injection into the skin of the opposite arm with an arrow indicating the direction of insertion.*

FDA Label Image

Figure N (Icatibant Fig15)

An instructional illustration depicting a hand administering a subcutaneous injection into the abdomen. The image shows a syringe angled towards the skin with an arrow indicating the direction of the injection.*

FDA Label Image

Figure O (Icatibant Fig16)

An instructional illustration showing one hand holding a syringe with its needle pointing downward into a puncture-resistant container labeled with a biohazard symbol and the warnings "DO NOT RECYCLE" and "CONTAINS SHARPS." The other hand is securing the container's lid, indicating proper disposal of used sharps.*

FDA Label Image

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syrine Label)

Icatibant Injection 30 mg per 3 mL (10 mg/mL) single-dose prefilled syringe label. For subcutaneous use only. Manufactured in India for Eugia US LLC, East Windsor, NJ. Includes NDC 55150-351-01 and barcodes.*

FDA Label Image

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe Carton (1 Syringe))

The packaging label for Icatibant Injection 30 mg per 3 mL (10 mg/mL) by Eugia US LLC is shown. The label includes the product name, strength, dosage form as a subcutaneous injection, and specifies that it is for prescription use only. It mentions that the carton contains one 3 mL single-dose prefilled syringe. Storage and inactive ingredient information are also visible, as well as barcode and manufacturer details.*

FDA Label Image

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe-Carton (3 Syringes))

Packaging label for Icatibant Injection 30 mg per 3 mL (10 mg/mL) solution for subcutaneous injection, distributed by Eugia US LLC. The carton contains three single-dose prefilled syringes. The label includes storage instructions, inactive ingredient details, and a barcode.*

FDA Label Image

Figure A (Icatibant Fig2)

An instructional illustration showing components of a prefilled syringe including the plunger, syringe barrel, and protective cap over the syringe tip. It also depicts a capped needle with needle, needle cap, and needle cap seal, alongside an alcohol wipe with a note indicating it is not included in the carton.*

FDA Label Image

Figure B (Icatibant Fig3)

Instructional diagram for Icatibant injection 30 mg per 3 mL, showing how to remove the prefilled syringe from its packaging by pulling the cap and tilting the box open. The syringe is labeled for subcutaneous use and single dosing.*

FDA Label Image

Figure C (Icatibant Fig4)

An instructional diagram showing one hand holding an injection pen or syringe and the other hand positioned to receive the subcutaneous injection, illustrating the proper handling technique for administering Icatibant injection solution.*

FDA Label Image

Figure D (Icatibant Fig5)

An instructional illustration showing hands using a syringe for subcutaneous injection. The image depicts removing the needle cap from the syringe prior to injection, demonstrating proper preparation steps for administering an injection.*

FDA Label Image

Figure E (Icatibant Fig6)

An instructional illustration showing a person holding a syringe with one hand while using the other hand to remove a cap by twisting it off, demonstrating preparation of an injection dose.*

FDA Label Image

Figure F (Icatibant Fig7)

Illustration showing the abdominal area with two shaded injection sites on either side of the navel, indicating recommended subcutaneous injection locations for Icatibant 30 mg/3 mL solution.*

FDA Label Image

Figure G (Icatibant Fig8)

Illustration showing a person holding the front of their lower abdomen with one hand, demonstrating a subcutaneous injection site likely related to Icatibant 30 mg/3 mL injection administration.*

FDA Label Image

Figure H (Icatibant Fig9)

A black and white instructional illustration showing one hand holding a vial and the other hand drawing liquid from the vial into a syringe. An arrow indicates the direction of fluid being drawn into the syringe. The image demonstrates the preparation of an injection dose for subcutaneous administration.*

FDA Label Image

Chemical Structure (Icatibant Str)

Chemical structure of the active ingredient icatibant, depicting its molecular composition with atoms and bonds arranged in a complex peptide-like chain, including a cyclic component and a repeating unit represented with parentheses and an 'n' subscript.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.